NCT06007690 · Interventional trial
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
Overall registry status Active not recruiting
Phase 3
Conditions Choroidal Melanoma, Indeterminate Lesions, Ocular Melanoma, Uveal Melanoma
Delaware Valley sites
- Shields & Shields PC-Wills Eye Institute · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory